tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

PEPG Stock Latest News

PepGen Inc. Faces Clinical Trial Challenges and Competitive Pressures Leading to Sell Rating
RatingsPepGen Inc. Faces Clinical Trial Challenges and Competitive Pressures Leading to Sell Rating
26d ago
PEPG
PepGen to pause CONNECT2-EDO51 study
PremiumThe Fly
PepGen to pause CONNECT2-EDO51 study
27d ago
PEPG
Promising Prospects for PepGen Inc.: Buy Rating Affirmed Amid Positive DM1 Treatment Developments
PremiumRatings
Promising Prospects for PepGen Inc.: Buy Rating Affirmed Amid Positive DM1 Treatment Developments
1M ago
PEPG
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
1M ago
PFE
AEON
PepGen Inc. Reports Positive Trial Results and Financials
PremiumCompany Announcements
PepGen Inc. Reports Positive Trial Results and Financials
1M ago
PEPG
Sell Rating on PepGen Inc. Amid Clinical and Regulatory Challenges
PremiumRatingsSell Rating on PepGen Inc. Amid Clinical and Regulatory Challenges
1M ago
PEPG
Apple to invest $500B in U.S., Domino’s reports downbeat Q4: Morning Buzz
Premium
The Fly
Apple to invest $500B in U.S., Domino’s reports downbeat Q4: Morning Buzz
1M ago
OC
APO
PepGen data ‘very encouraging’ for program, says H.C. Wainwright
Premium
The Fly
PepGen data ‘very encouraging’ for program, says H.C. Wainwright
1M ago
PEPG
Promising Initial Data and Safety Profile Boost PepGen’s FREEDOM-DM1 Trial Outlook
PremiumRatings
Promising Initial Data and Safety Profile Boost PepGen’s FREEDOM-DM1 Trial Outlook
1M ago
PEPG
PepGen initial DM1 data ‘a clear win,’ says Stifel
PremiumThe Fly
PepGen initial DM1 data ‘a clear win,’ says Stifel
1M ago
PEPG
PepGen Inc. Announces Positive FREEDOM-DM1 Trial Results
PremiumCompany Announcements
PepGen Inc. Announces Positive FREEDOM-DM1 Trial Results
1M ago
8K
PEPG
PepGen reports Q2 EPS (68c), consensus (72c)
PremiumThe Fly
PepGen reports Q2 EPS (68c), consensus (72c)
1M ago
PEPG
PepGen announces initial clinical data from cohorts in FREEDOM-DM1 trial
PremiumThe FlyPepGen announces initial clinical data from cohorts in FREEDOM-DM1 trial
1M ago
PEPG
PepGen price target lowered to $16 from $26 at H.C. Wainwright
Premium
The Fly
PepGen price target lowered to $16 from $26 at H.C. Wainwright
2M ago
PEPG
PepGen announces CONNECT program updates
Premium
The Fly
PepGen announces CONNECT program updates
2M ago
PEPG
Jefferies healthcare analyst holds an analyst/industry conference call
PremiumThe Fly
Jefferies healthcare analyst holds an analyst/industry conference call
3M ago
RNA
CAPR
PepGen clinical hold likely to be resolved quickly, says Leerink
PremiumThe Fly
PepGen clinical hold likely to be resolved quickly, says Leerink
3M ago
PEPG
BofA downgrades PepGen to Underperform after clinical hold
PremiumThe Fly
BofA downgrades PepGen to Underperform after clinical hold
3M ago
PEPG
PepGen downgraded to Underperform from Neutral at BofA
PremiumThe Fly
PepGen downgraded to Underperform from Neutral at BofA
3M ago
PEPG
FDA issues clinical hold notice to PepGen on IND app for CONNECT2-EDO51 trial
PremiumThe FlyFDA issues clinical hold notice to PepGen on IND app for CONNECT2-EDO51 trial
3M ago
PEPG
Two new option listings and one option delisting on November 21st
Premium
The Fly
Two new option listings and one option delisting on November 21st
4M ago
EXAI
PEPG
PepGen price target lowered to $6 from $10 at BofA
Premium
The Fly
PepGen price target lowered to $6 from $10 at BofA
4M ago
PEPG

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >